@FierceBiotech: UPDATED: Suicide stunner prompts Amgen to dump brodalumab, denting AstraZeneca's rep. Story | Follow @FierceBiotech
@JohnCFierce: CAR-T powerhouse Juno allies with gene-editing upstart Editas in $737M deal. Article | Follow @JohnCFierce
> Corporate governance adviser Institutional Shareholder Services (ISS) believes Vertex ($VRTX) chief Jeff Leiden is overpaid. ISS is urging shareholders to censure the executive pay in a non-binding vote of disapproval June 4, reports Bloomberg. Leiden's pay packet last year was worth $45.8 million. Story
> Houston-based Pulmotect has won a $3 million grant from the NIH to help advance its immunotherapy in the clinic. Story
Medical Device News
@FierceMedDev: ICYMI yesterday: SI-Bone raises $21M, brings on new CFO to grow iFuse implant sales. Article | Follow @FierceMedDev
@VarunSaxena2: Pacira's liposomal-encased bupivacaine gets positive reviews at breast cancer conference. FierceDrugDelivery story | Follow @VarunSaxena2
@EmilyWFierce: Cancer Genetics strikes genomics deal with Japanese regenerative medicine company. More from FierceDiagnostics | Follow @EmilyWFierce
> CareFusion's Avea ventilator recalled as potentially deadly, FDA says it may cease functioning. Article
> Scientists push back against cancer hereditary genetic tests in NEJM paper. More
> Varian, Flatiron Health to collaborate on oncology electronic health records. Report
Pharma News
@FiercePharma: Regeneus gets green light to move personalized cancer vaccine into PhI. FierceVaccines story | Follow @FiercePharma
@CarlyHFierce: AZ, Daiichi sign up Olympian Joyner-Kersee, hoping OIC patients will make tracks to Movantik. FiercePharmaMarketing article | Follow @CarlyHFierce
> Express Scripts pushes pay-for-performance to cut cancer drug prices. Report
> Top Medicare prescribers get top payments from drugmakers: Modern Healthcare. More
> Vertex CEO's $45.8M paycheck spurs call for revolt. Article
Pharma Marketing News
> My bathtub or yours? How a panned Cialis ad became promotional gold. More
> Revving up for price war with Amgen, Sanofi plots low-cost starter dose of PCSK9 med. Story
> Do doc payments push prescriptions? Study of Medicare scripts suggests it's so. Item
> AZ, Daiichi sign up Olympian Joyner-Kersee, hoping OIC patients will make tracks to Movantik. Article
> Can AZ salvage brodalumab against next-gen psoriasis field? More
Biotech Research News
> Dana-Farber researchers tout a new class of cancer-fighting 'degronimids.' More
> Pitt team unveils two new classes of RNAs for cancer drug R&D. Report
> The White House draws the line against CRISPR/Cas9-designed embryos. Story
> Thunder god vine compound may have potent anti-obesity characteristics. More
> Winship research team flags potential of a new lung cancer therapy. Article
Diagnostics News
> MBio receives $6.3M in support of its portable, optical diagnostic. Story
> Cancer Genetics strikes genomics deal with Japanese regenerative medicine company. Item
> Quest Diagnostics shares hit record high amid takeover rumors. Report
> Roche gets FDA green light for quick C. difficile test. Article
> Sequenom stares down suit from Indian genomics firm. More